Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
lung cancer
Jun 14, 2024, 12:31 |
Blog
Herbert Loong: Our CUHK Sarcoma Masterclass is kicking off in less than 96 hours
Herbert Loong shared on LinkedIn: . "Our CUHK Sarcoma Masterclass…
Jun 14, 2024, 05:01 |
Insight
Mark Doolan: Our NoeticInsight team with Illuminate Health kicked off a series of meetings at ASCO24
Mark Doolan, Senior Vice President and Managing Director at NoeticInsight, shared on LinkedIn: “What a…
Jun 14, 2024, 03:35 |
Blog
Stephen V Liu: ASCO24 highlights with Drs. Lecia Sequist and David R. Spigel
Stephen V Liu shared the following on X: “In the latest episode of the IASLC…
Jun 13, 2024, 15:48 |
Insight
Stephen Liu on a paper by Natasha Leighl, et al.
Stephen Liu recently shared a post on X: "PALOMA-3 results at Journal of Clinical Oncology…
Jun 13, 2024, 13:34 |
Insight
Stephen Liu: Report on brain metastases in patients with KRAS NSCLC
Stephen Liu shared on X/Twitter: "Report on brain metastases in patients with KRAS NSCLC in phase…
Jun 12, 2024, 05:43 |
Blog
Mia Levy: A few highlights from my time at ASCO24
Mia Levy, Chief Medical Officer at Foundation Medicine, shared a post on LinkedIn: ''And that…
Jun 11, 2024, 14:31 |
Insight
Sofia Tzamarelou: Georgi Ivanov wrote a fantastic piece on ASCO 2024
Sofia Tzamarelou, Senior Consultant at Commetric, shared on LinkedIn: “Our very own Georgi Ivanov wrote…
Jun 11, 2024, 12:52 |
Dialogues
ASCO24 Updates: Survival Outcomes: Neoadjuvant vs. Adjuvant Therapy in NSCLC
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…
Jun 10, 2024, 16:18 |
Blog
Estela Rodriguez: Disparities in survival among patients with metastatic NSCLC via JNCI
Estela Rodriguez shared a post on X: "Racial and socioeconomic disparities in survival among patients with…
Jun 10, 2024, 11:09 |
Insight
Phase II BLOSSOM Trial Osimertinib in LMD from EGFR+ NSCLC by Sehhoon Park et al.
Jarushka Naidoo shared a post on X: "Phase II BLOSSOM Trial Osimertinib in LMD (leptomeningeal…
104
105
106
107
108
All:
1579
Posts:
1051 - 1060
Tsetsegsaikhan Batmunkh: Honored to be nominated for the board of directors of the UICC
New management team at St. Anna Children's Hospital
Key Inspirational Moments with WHO Director at the Olympic Games
Remembering Susan Wojcicki, Honoring a Legacy of Leadership and Technological Innovation
MASCC24 Highlights: The Ideal Location for Care Varies According to Disease, Patient and Family Characteristics
Facebook
RSS Feed
Twitter
Linkedin
Youtube